PRAA vs. BIO
PRAA (PRA Group, Inc.) and BIO (Bio-Rad Laboratories, Inc.) are both stocks. PRAA operates in Credit Services (Financial Services), while BIO operates in Medical Devices (Healthcare). Over the past 10 years, PRAA returned -3.65%/yr vs 7.41%/yr for BIO. At a 0.31 correlation, their price movements are largely independent.
Performance
PRAA vs. BIO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PRAA achieves a 4.52% return, which is significantly higher than BIO's -2.27% return. Over the past 10 years, PRAA has underperformed BIO with an annualized return of -3.65%, while BIO has yielded a comparatively higher 7.41% annualized return.
PRAA
- 1D
- 1.20%
- 1M
- 19.14%
- 6M
- 5.36%
- YTD
- 4.52%
- 1Y
- 17.10%
- 3Y*
- -5.43%
- 5Y*
- -13.23%
- 10Y*
- -3.65%
BIO
- 1D
- -0.39%
- 1M
- 3.56%
- 6M
- -8.56%
- YTD
- -2.27%
- 1Y
- 15.23%
- 3Y*
- -9.17%
- 5Y*
- -15.20%
- 10Y*
- 7.41%
PRAA vs. BIO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PRAA PRA Group, Inc. | 4.52% | -15.32% | -20.27% | -22.44% | -32.72% | 26.60% | 9.26% | 48.95% | -26.60% | -15.09% |
BIO Bio-Rad Laboratories, Inc. | -2.27% | -7.77% | 1.74% | -23.21% | -44.35% | 29.61% | 57.54% | 59.34% | -2.70% | 30.94% |
Correlation
The correlation between PRAA and BIO is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.31 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.36 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.30 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.25 |
Correlation (All Time) Calculated using the full available price history since Nov 8, 2002 | 0.31 |
The correlation between PRAA and BIO shifts across timeframes, from 0.25 (10 years) to 0.36 (3 years), reflecting how their relationship changes across market environments.
Fundamentals
PRAA:
$705.23M
BIO:
$8.01B
PRAA:
-$7.21
BIO:
$6.26
PRAA:
0.56
BIO:
3.08
PRAA:
0.71
BIO:
1.17
PRAA:
$1.28B
BIO:
$2.59B
PRAA:
$1.31B
BIO:
$1.34B
PRAA:
-$47.90M
BIO:
$746.20M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PRAA vs. BIO — Risk / Return Rank
PRAA
BIO
PRAA vs. BIO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for PRA Group, Inc. (PRAA) and Bio-Rad Laboratories, Inc. (BIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PRAA | BIO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.09 | ||
| Sortino ratioReturn per unit of downside risk | -0.07 | ||
| Omega ratioGain probability vs. loss probability | 1.10 | 1.11 | 0.00 |
| Calmar ratioReturn relative to maximum drawdown | 0.33 | 0.49 | -0.16 |
| Martin ratioReturn relative to average drawdown | 0.80 | 1.09 | -0.29 |
Loading charts...
Drawdowns
PRAA vs. BIO - Drawdown Comparison
The maximum PRAA drawdown since its inception was -83.83%, roughly equal to the maximum BIO drawdown of -83.64%. Use the drawdown chart below to compare losses from any high point for PRAA and BIO.
Loading charts...
Drawdown Indicators
| PRAA | BIO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.83% | -83.64% | -0.19% |
Max Drawdown (1Y)Largest decline over 1 year | -42.34% | -28.86% | -13.48% |
Max Drawdown (3Y)Largest decline over 3 years | -62.79% | -48.76% | -14.03% |
Max Drawdown (5Y)Largest decline over 5 years | -79.35% | -73.77% | -5.58% |
Max Drawdown (10Y)Largest decline over 10 years | -79.35% | -73.77% | -5.58% |
Current DrawdownCurrent decline from peak | -71.32% | -64.14% | -7.18% |
Average DrawdownAverage peak-to-trough decline | -32.42% | -27.81% | -4.61% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.39% | 12.83% | +4.56% |
Volatility
PRAA vs. BIO - Volatility Comparison
PRA Group, Inc. (PRAA) has a higher volatility of 15.73% compared to Bio-Rad Laboratories, Inc. (BIO) at 11.24%. This indicates that PRAA's price experiences larger fluctuations and is considered to be riskier than BIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PRAA | BIO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.73% | 11.24% | +4.49% |
Volatility (6M)Calculated over the trailing 6-month period | 49.90% | 29.92% | +19.98% |
Volatility (1Y)Calculated over the trailing 1-year period | 58.48% | 42.20% | +16.28% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 50.09% | 37.58% | +12.51% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 46.67% | 34.19% | +12.48% |
Dividends
PRAA vs. BIO - Dividend Comparison
Neither PRAA nor BIO has paid dividends to shareholders.
Financials
PRAA vs. BIO - Financials Comparison
This section allows you to compare key financial metrics between PRA Group, Inc. and Bio-Rad Laboratories, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
PRAA vs. BIO - Profitability Comparison
PRAA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, PRA Group, Inc. reported a gross profit of 243.80M and revenue of 314.53M. Therefore, the gross margin over that period was 77.5%.
BIO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Bio-Rad Laboratories, Inc. reported a gross profit of 309.40M and revenue of 592.10M. Therefore, the gross margin over that period was 52.3%.
PRAA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, PRA Group, Inc. reported an operating income of 103.25M and revenue of 314.53M, resulting in an operating margin of 32.8%.
BIO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Bio-Rad Laboratories, Inc. reported an operating income of 34.10M and revenue of 592.10M, resulting in an operating margin of 5.8%.
PRAA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, PRA Group, Inc. reported a net income of 28.21M and revenue of 314.53M, resulting in a net margin of 9.0%.
BIO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Bio-Rad Laboratories, Inc. reported a net income of -527.10M and revenue of 592.10M, resulting in a net margin of -89.0%.
Frequently Asked Questions
PRAA and BIO have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PRAA has higher volatility (15.73%) compared to BIO (11.24%). In terms of maximum drawdown, PRAA dropped -83.83% vs BIO's -83.64%.
BIO currently has the higher Sharpe Ratio (0.33 vs 0.24), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PRAA and BIO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer